ERK5 signaling, a MAP kinase family member, induces PPARδ, which is protective against stroke-induce brain injuries and its agonists are suggested as potential stroke treatments (Woo et al., 2006; Yin et al., 2011; Jin et al., 2013; Su et al., 2014). The gene discussed is PPARD; the disease is stroke disorder.